Invesco’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Buy
267,490
+84,654
+46% +$580K ﹤0.01% 2530
2025
Q4
$362K Buy
182,836
+23,353
+15% +$52.9K ﹤0.01% 3318
2025
Q3
$392K Buy
159,483
+29,332
+23% +$75.5K ﹤0.01% 3318
2025
Q2
$344K Buy
130,151
+20,013
+18% +$53.8K ﹤0.01% 3319
2025
Q1
$332K Buy
110,138
+44,442
+68% +$135K ﹤0.01% 3321
2024
Q4
$168K Buy
65,696
+2,911
+5% +$12.1K ﹤0.01% 3541
2024
Q3
$234K Buy
62,785
+1,770
+3% +$8.19K ﹤0.01% 3485
2024
Q2
$386K Sell
61,015
-1,206,127
-95% -$7.95M ﹤0.01% 3388
2024
Q1
$6.8M Buy
1,267,142
+625,779
+98% +$2.83M ﹤0.01% 2043
2023
Q4
$3.22M Buy
641,363
+595,890
+1,310% +$1.87M ﹤0.01% 2440
2023
Q3
$76.8K Buy
45,473
+792
+2% +$1.59K ﹤0.01% 3758
2023
Q2
$124K Buy
44,681
+2,450
+6% +$6.93K ﹤0.01% 3689
2023
Q1
$76.9K Sell
42,231
-290,625
-87% -$904K ﹤0.01% 3725
2022
Q4
$1.69M Buy
332,856
+291,110
+697% +$1.6M ﹤0.01% 2715
2022
Q3
$207K Buy
41,746
+2,694
+7% +$12.3K ﹤0.01% 3670
2022
Q2
$145K Buy
39,052
+3,344
+9% +$13.4K ﹤0.01% 3813
2022
Q1
$200K Buy
35,708
+2,496
+8% +$15.3K ﹤0.01% 3773
2021
Q4
$202K Sell
33,212
-7,785
-19% -$58.5K ﹤0.01% 3773
2021
Q3
$399K Buy
40,997
+740
+2% +$8.14K ﹤0.01% 3530
2021
Q2
$575K Buy
40,257
+29,535
+275% +$488K ﹤0.01% 3352
2021
Q1
$254K Sell
10,722
-333,017
-97% -$8.63M ﹤0.01% 3607
2020
Q4
$4.58M Buy
+343,739
New +$3.31M ﹤0.01% 2235
2020
Q3
Sell
-449,003
Closed -$5.51M 3648
2020
Q2
$5.51M Buy
449,003
+426,903
+1,932% +$2.41M ﹤0.01% 1942
2020
Q1
$64K Buy
+22,100
New +$111K ﹤0.01% 3595
2018
Q2
Sell
-23,000
Closed -$89K 3893
2018
Q1
$89K Buy
23,000
+12,810
+126% +$56.2K ﹤0.01% 3670
2017
Q4
$46K Sell
10,190
-124,362
-92% -$589K ﹤0.01% 3634
2017
Q3
$737K Buy
134,552
+124,061
+1,183% +$765K ﹤0.01% 3160
2017
Q2
$80K Buy
+10,491
New +$45.3K ﹤0.01% 3656

Other funds holding IBRX